This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: University Health Network. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Sam Saibil: Innovator in Anti-Cancer T Cell Research
Introduction
Sam Saibil is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of immunology, particularly in the development of anti-cancer therapies. His innovative approach focuses on harnessing the power of T cells to combat cancer effectively.
Latest Patents
Sam Saibil holds a patent for a method involving anti-cancer T cells and their preparation using coenzyme A. The patent describes a method for inducing Tc22 lineage T cells from a population of CD8+ T cells. This method includes providing a population of CD8+ T cells, activating the population, and culturing or contacting the population with coenzyme A. This groundbreaking work has the potential to enhance cancer treatment strategies.
Career Highlights
Sam Saibil is affiliated with the University Health Network, where he conducts his research. His work has garnered attention for its innovative approach to cancer therapy. With a focus on T cell manipulation, he aims to improve patient outcomes in cancer treatment.
Collaborations
Sam collaborates with esteemed colleagues, including Pamela S. Ohashi and Michael St. Paul. Their combined expertise contributes to advancing research in the field of immunotherapy.
Conclusion
Sam Saibil's contributions to anti-cancer T cell research exemplify the impact of innovation in medicine. His work not only highlights the importance of T cell therapy but also paves the way for future advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile